tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Ownership - Who Owns MiNK Therapeutics?

Compare
141 Followers

MiNK Therapeutics (INKT) Ownership Overview

28.89%8.28%0.45%5.97%56.86%
28.89% Insiders
0.45% Other Institutional Investors
5.97% ETFs
56.86% Public Companies and Individual Investors
The ownership structure of MiNK Therapeutics (INKT) stock is a mix of institutional, retail, and individual investors. Approximately 14.69% of the company’s stock is owned by Institutional Investors, 28.89% is owned by Insiders, and 56.86% is owned by Public Companies and Individual Investors.
The ownership structure of MiNK Therapeutics (INKT) stock is a mix of institutional, retail, and individual investors. Approximately 8.73% of the company’s stock is owned by Institutional Investors, 28.89% is owned by Insiders, and 5.97% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
426,283Insider10.76%4,048,410
422,481Insider10.66%4,012,302
234,182Institution5.91%2,224,026
234,182Institution5.91%2,224,026
150,336Insider3.79%1,427,741
133,634Insider3.37%1,269,122
93,903Institution2.37%891,797
12,286Insider0.31%116,680
2,279Institution0.06%21,644

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
234,182Institution5.91%2,224,026
93,903Institution2.37%891,797

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
148,229Institution3.74%103,301
85,953Institution2.17%59,901
2,263Institution0.06%21,295

FAQ

Who Owns MiNK Therapeutics (INKT)?
According to the latest TipRanks data, approximately 0.45% of the company's stock is held by institutional investors, 28.89% is held by insiders, and 56.86% is held by retail investors.
    What percentage of MiNK Therapeutics (INKT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.45% of MiNK Therapeutics (INKT) stock is held by institutional investors.
      What percentage of MiNK Therapeutics (INKT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 56.86% of MiNK Therapeutics (INKT) stock is held by retail investors.
        Who owns the most shares of MiNK Therapeutics (INKT)?
        Brian Corvese owns the most shares of MiNK Therapeutics (INKT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis